Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Autoimmune Disorders01:29

Autoimmune Disorders

1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Annals of neurology·2026
Same author

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Neurology·2026
Same author

Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.

Multiple sclerosis and related disorders·2026

関連する実験動画

Updated: Jan 14, 2026

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.9K

自己免疫性脳炎に対する免疫療法

Cynthia M C Lemmens1, Agnes Van Sonderen1, Maarten J Titulaer2

  • 1Department of Neurology, Haaglanden Medical Center, The Hague, South Holland, The Netherlands.

Handbook of clinical neurology
|January 12, 2026
PubMed
まとめ

自己免疫性脳炎（AE）は、自己抗体によって引き起こされる炎症性脳疾患です。ステロイドやIVIgを含む早期の免疫療法は、寛解につながり、転帰を改善することができます。

科学分野:

  • 神経免疫学
  • 神経学
  • 内科学

背景:

  • 自己免疫性脳炎（AE）は、多様な炎症性神経疾患である。
  • 神経成分を標的とする自己抗体から生じ、認知低下、痙攣、自律神経機能不全などの多様な症状を引き起こす。

研究 の 目的:

  • 自己免疫性脳炎の現在の理解を要約すること。
  • AEの診断および治療戦略の概略を示すこと。

主な方法:

  • 自己免疫性脳炎に関する既存の文献のレビュー。
  • 臨床的特徴、診断アプローチ、および治療転帰の分析。

主要な成果:

  • AEは、特定の自己抗原に基づいて異種な様相を呈する。
  • 早期の診断と免疫療法は、良好な予後にとって極めて重要である。
  • 第一線の治療には、高用量グルココルチコイド、IVIg、および血漿交換が含まれる。
  • リツキシマブまたはシクロホスファミドなどの第二線の治療は、重症または再発性の症例に使用される。

結論:

  • 自己免疫性脳炎は、タイムリーな診断と積極的な免疫療法を必要とする。
キーワード:
自己抗体自己免疫性脳炎（AE）GAD65免疫療法LGI1NMDAR難治性

さらに関連する動画

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.2K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K

関連する実験動画

Last Updated: Jan 14, 2026

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

2.9K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.2K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K
  • 確立された治療法は存在するが、ランダム化比較試験を含むさらなる研究が必要である。
  • 新しい治療法が出現しているが、その有効性にはより多くのデータが必要である。